These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5594382)

  • 21. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
    [No Abstract]   [Full Text] [Related]  

  • 23. [EXPERIMENTAL STUDY OF THE ANTI-ALCOHOL ACTION OF VARIOUS SUBSTANCES].
    ROYER R; LAMARCHE M
    J Physiol (Paris); 1964; 56():437-8. PubMed ID: 14219854
    [No Abstract]   [Full Text] [Related]  

  • 24. Study of liver functions in cases of diabetes mellitus receiving sulphonylureas.
    Dube BK; Kumar A
    Indian Pract; 1966 Oct; 19(10):679-87. PubMed ID: 5923489
    [No Abstract]   [Full Text] [Related]  

  • 25. Postreceptor regulation of insulin action in primary cultures of rat hepatocytes by oral hypoglycemic agents: effects of linogliride and chlorpropamide.
    Salhanick AI; Leighty SJ; Amatruda JM
    Horm Metab Res; 1989 Nov; 21(11):596-601. PubMed ID: 2687145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modification by certain hypoglycemic sulfonamides of lipid disturbances induced by cholesterol administration in rabbits].
    Marquié G; Agid R
    C R Seances Soc Biol Fil; 1968; 162(2):563-8. PubMed ID: 4237632
    [No Abstract]   [Full Text] [Related]  

  • 27. [Action of tolbutamide, chlorpropamide and insulin on hyperglycemia induced by non-thiazide diuretics in rats].
    Coppi G; Bonardi G
    Boll Soc Ital Biol Sper; 1969 Jan; 45(2):124-6. PubMed ID: 5346778
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mode of action of blood glucose lowering sulfonamides. Other extrapancreatic effects].
    Madsen J
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():415-28. PubMed ID: 4906023
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diuretic and natriuric action of chlorpropamide in rats with water overload. Comparison with tolbutamide].
    Gharib C; Burguburu AM; Rivet O; Sassard J; Biron A; de Serre S
    Lyon Med; 1970 Dec; 224(41):839-43. PubMed ID: 5485441
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental study of the hypoglycemic effect of some antidiabetic plants.
    Román-Ramos R; Flores-Sáenz JL; Partida-Hernández G; Lara-Lemus A; Alarcón-Aguilar F
    Arch Invest Med (Mex); 1991; 22(1):87-93. PubMed ID: 1819981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of nitric oxide (NO) in hypoglycaemic activity of tolbutamide.
    Satyanarayana S; Krishnaiah YS; Rao BK
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):551-4. PubMed ID: 10874360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the acute hypoglycemic potencies of tolbutamide and chlorpropamide.
    CRAIG JW; MILLER M; MILLS FD; NICKERSON N
    Ann N Y Acad Sci; 1959 Mar; 74(3):618-20. PubMed ID: 13637599
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative characteristics of the hypoglycemic effect of a new 3,5-dioxopyrazolidine derivative, DSB, and butamide].
    Voronkova LA
    Farmakol Toksikol; 1973; 36(5):706-7. PubMed ID: 4802162
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of HB 419 and tolbutamide on isolated islands of Langerhans in rats].
    Löffler G; Trautschold I; Schweitzer T; Lohmann E
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1469-72. PubMed ID: 4899090
    [No Abstract]   [Full Text] [Related]  

  • 35. Potentiation of the hypoglycaemic action of tolbutamide by different drugs.
    Mahfouz M; Abdel-Maguid R; el-Dakhakhny M
    Arzneimittelforschung; 1970 Jan; 20(1):120-2. PubMed ID: 5467602
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trial with tolazamide, a new hypoglycemia agent; its potency compared to chlorpropamide.
    Quismorio FT; Villadolid LS; Egay LM; Wico AR; Llamas SP; Acurantes AI
    Acta Med Philipp; 1967; 3(4):261-5. PubMed ID: 6069635
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets.
    Del Guerra S; Marselli L; Lupi R; Boggi U; Mosca F; Benzi L; Del Prato S; Marchetti P
    J Diabetes Complications; 2005; 19(1):60-4. PubMed ID: 15642492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative hypoglycemic effects of chlorpropamide, tolbutamide, and furfurylurea.
    DANOWSKI TS; MATEER FM
    Ann N Y Acad Sci; 1959 Mar; 74(3):971-8. PubMed ID: 13637641
    [No Abstract]   [Full Text] [Related]  

  • 39. Sulphonylureas and biguanides do not affect insulin binding in H35 hepatoma cells.
    De Vries CP; van der Veen EA
    Diabetes Res; 1986 Jul; 3(6):307-10. PubMed ID: 3757414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro effect of various hypoglycemic agents on the hepatic and pancreatic protein synthesis in the rat.
    Wacker A; Chandra P; Wacker D
    Horm Metab Res; 1971 Sep; 3(5):357-8. PubMed ID: 5002750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.